CONTINUOUS INTRA-ARTERIAL OR INTRAVENOUS INFUSION OF 5-FLUORO-2-DEOXYURIDINE: THERAPEUTIC AND TOXIC EFFECTS.
D000230:Adenocarcinoma; D002277:Carcinoma; D002294:Carcinoma, Squamous Cell; D002339:Carotid Arteries; D010478:Chemotherapy, Cancer, Regional Perfusion; D005260:Female; D005467:Floxuridine; D005928:Glossitis; D006197:Hair; D006801:Humans; D007262:Infusions, Intravenous; D008113:Liver Neoplasms; D016403:Lymphoma, Large B-Cell, Diffuse; D008228:Lymphoma, Non-Hodgkin; D009303:Nasopharyngeal Neoplasms; D009369:Neoplasms; D012468:Salivary Gland Neoplasms; D012509:Sarcoma; D013280:Stomatitis; D013936:Thymidine; D014062:Tongue Neoplasms; D014067:Tonsillar Neoplasms; D014116:Toxicology; D002583:Uterine Cervical Neoplasms
D005467:Floxuridine; D013936:Thymidine
ADENOCARCINOMA; CARCINOMA; CARCINOMA, EPIDERMOID; CAROTID ARTERIES; CERVIX NEOPLASMS; FLUORODEOXYURIDINE; GLOSSITIS; HAIR; ISOLATION PERFUSION; LIVER NEOPLASMS; NASOPHARYNGEAL NEOPLASMS; SALIVARY GLAND NEOPLASMS; SARCOMA, RETICULUM CELL; STOMATITIS; THYMIDINE; TONGUE NEOPLASMS; TONSILLAR NEOPLASMS; TOXICOLOGIC REPORT